| SIA "Centrālā laboratorija" Rēzeknes filiāles (18. Novembra iela 41 , Rēzekne) veikto testu nenoteiktība kvantitatīvajām metodēm 2020. gadā | |||||
|---|---|---|---|---|---|
| Tests | Iekārta | Nenoteiktība, CV% | Kopējā pieļaujamā nenoteiktība*, CV % | ||
| Vidējais līmenis | Augstais līmenis | Zemais līmenis | |||
| Hematoloģija | |||||
| Leikocīti | Sysmex XN 1000 | 1.6 | 1.5 | 2.4 | 18 |
| Sysmex XP-300 | 1.2 | 1.4 | 2 | ||
| Eritrocīti | Sysmex XN 1000 | 0.8 | 0.9 | 1 | 8 |
| Sysmex XP-300 | 0.6 | 0.7 | 7 | ||
| Hemoglobīns | Sysmex XN 1000 | 0.8 | 0.8 | 1 | 6 |
| Sysmex XP-300 | 0.9 | 0.9 | |||
| Hematokrīts | Sysmex XN 1000 | 1.3 | 1.3 | 1 | 9 |
| Sysmex XP-300 | 1 | 0.9 | 1 | ||
| MCV | Sysmex XN 1000 | 1 | 1 | 0.7 | 5 |
| Sysmex XP-300 | 0.6 | 0.8 | 1 | ||
| Trombocīti | Sysmex XN 1000 | 0.8 | 1.7 | 3.9 | 15 |
| Sysmex XP-300 | 3 | 2.9 | 7 | ||
| Neitrofīli (%) | Sysmex XN 1000 | 2.2 | 2.1 | 2.2 | 30 |
| Sysmex XP-300 | 2 | 2 | 3.5 | ||
| Limfocīti (%) | Sysmex XN 1000 | 2.7 | 2.3 | 3.5 | 30 |
| Sysmex XP-300 | 2.5 | 2 | 3.6 | ||
| Monocīti (%) | Sysmex XN 1000 | 5.8 | 5 | 8.2 | 30 |
| Sysmex XP-300 | 7 | 7.2 | 7 | ||
| Eozinofīli (%) | Sysmex XN 1000 | 7.1 | 7.2 | 7.8 | 30 |
| Sysmex XP-300 | - | - | - | ||
| Bazofīli (%) | Sysmex XN 1000 | 2.8 | 2.4 | 3.9 | 30 |
| Sysmex XP-300 | - | - | - | ||
| EGĀ | Alifax Roller 20PN | 3,0 | 2.9 | 7 | 30 |
| Hemostāze | |||||
| Protrombīns un INR | Sysmex CS-2100i | 6.7 | 4.9 | - | 23 |
| APTL | Sysmex CS-2100i | 3.2 | 4 | - | 18 |
| D-dimēri | Sysmex CS-2100i | 6 | - | 6 | 20 |
| Fibrinogēns | Sysmex CS-2100i | 8.2 | - | - | 20 |
| Klīniskā ķīmija. Imūnķīmija. Imunoloģija | |||||
| Ferritīns | Abbott Architect | 4.3 | 7.2 | 5.2 | 14.1 |
| Kopējais bilirubīns | Abbott Architect | 6.9 | 6.1 | - | 22 |
| Tiešais bilirubīns | Abbott Architect | 8.6 | 5 | - | 36 |
| ALAT | Abbott Architect | 5.4 | 2.7 | - | 21 |
| ASAT | Abbott Architect | 2.8 | 1.6 | - | 21 |
| Amilāze | Abbott Architect | 2.1 | 2.1 | - | 30 |
| Sārmainā fosfotāze | Abbott Architect | 6.2 | 5.3 | - | 18 |
| Kreatīnkināze | Abbott Architect | 3.4 | 4.7 | - | 20 |
| GGT | Abbott Architect | 7.6 | 3 | - | 21 |
| LDH | Abbott Architect | 5.2 | 3.6 | - | 18 |
| Urīnviela | Abbott Architect | 5.3 | 4.7 | - | 20 |
| Kreatinīns | Abbott Architect | 4.5 | 3.4 | - | 20 |
| Urīnskābe | Abbott Architect | 3 | 3.4 | - | 13 |
| Glikolizētais hemoglobīns | Abbott Architect | 7.7 | 9 | - | 18 |
| Glikoze | Abbott Architect | 2.5 | 2.5 | - | 15 |
| Kopējais olbaltums | Abbott Architect | 7 | 7.2 | - | 10 |
| Albumīns | Abbott Architect | 2.3 | 2.5 | - | 20 |
| C-reaktīvais olbaltums | Abbott Architect | 7.2 | 6.2 | - | 20 |
| Reimatoīdais faktors | Abbott Architect | 4.2 | - | - | 20 |
| Antistreptolizīns O | Abbott Architect | 3 | - | - | 20 |
| Nātrijs | Abbott Architect | 1.8 | 1.8 | - | 5 |
| Kālijs | Abbott Architect | 2.1 | 1.7 | - | 8 |
| Kalcijs | Abbott Architect | 2.6 | 2.7 | - | 10 |
| Neorganiskais fosfors | Abbott Architect | 3.1 | 2.3 | - | 16 |
| Hlors | Abbott Architect | 1.8 | 1.5 | - | 8 |
| Magnijs | Abbott Architect | 4.8 | 3.9 | - | 15 |
| Kopējais holesterīns | Abbott Architect | 2.1 | 2.9 | - | 13 |
| Etanols | Abbott Architect | - | 2.8 | 5.8 | 8 |
| Troponīns I | Abbott Architect | 8.8 | 4.3 | 6 | 15 |
| Mikroalbumīns | Abbott Architect | 6.5 | - | 8.9 | 10 |
| Olbaltums urīnā | Abbott Architect | - | - | 10.9 | 50 |
| CK-MB | Abbott Architect | 5.9 | - | - | 12 |
| Dzelzs | Abbott Architect | 4 | 3.9 | - | 36 |
| ABL holesterīns | Abbott Architect | 7.9 | 5.9 | - | 36 |
| ZBL holesterīns | Abbott Architect | 9.3 | 6.4 | - | 36 |
| Triglicerīdi | Abbott Architect | 2.9 | 2.9 | - | 16 |
| Brīvais T3 | Abbott Architect | 4.6 | 4.8 | 10 | 20 |
| TSH | Abbott Architect | 3.7 | 4.2 | 4.3 | 24 |
| Vitamīns B12 | Abbott Architect | 10.3 | 10 | 14.49 | 25 |
| 25 (OH) Vitamīns D | Abbott Architect | 5.2 | 3.3 | 5.8 | 36 |
| Brīvais T4 | Abbott Architect | 8,0 | 16.1 | 4.4 | 20 |
| Anti-HCV | Abbott Architect | 14 | - | 6.1 | 28 |
| HbsAg | Abbott Architect | 18.4 | - | 15 | 26 |
| HIV Ag/Av | Abbott Architect | 30 | 14.5 | 11.1 | 30 |
| Kopējais PSA | Abbott Architect | 8.5 | 9.2 | 4 | 19.4 |
| Lipāze | Abbott Architect | 4.6 | 5.4 | - | 25 |
| Antivielas pret tireoglobulīnu | Abbott Architect | 12,3 | - | 18 | 20 |
| Antivielas pret tireoperoksidāzi | Abbott Architect | 18,0 | - | 16.7 | 20 |
| C-peptīds | Abbott Architect | 4 | 7.4 | 4.9 | 20 |
